Mount Yale Investment Advisors’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-447
Closed -$12K 562
2018
Q3
$12K Sell
447
-331
-43% -$11.9K ﹤0.01% 838
2018
Q2
$26K Sell
778
-2
-0.3% -$71 ﹤0.01% 747
2018
Q1
$28K Buy
+780
New +$27K 0.01% 717

Other funds holding LMAT

Mount Yale Investment Advisors's LMAT Position: Q4 2018 in Review

Mount Yale Investment Advisors sold out of LeMaitre Vascular (LMAT) in Q4 2018, closing a stake of 447 shares — an estimated $12K sold.

Mount Yale Investment Advisors first reported a position in LMAT in Q1 2018 and held it in 3 quarters. The position peaked at $28K in Q1 2018. 139 funds tracked by Wall St. Rank hold LMAT as of Q4 2018.

  • Mount Yale Investment Advisors reported no remaining LeMaitre Vascular position as of Q4 2018 after selling out during the quarter.
  • Mount Yale Investment Advisors sold 447 LeMaitre Vascular shares in Q4 2018, an estimated $12K.
  • Mount Yale Investment Advisors first reported a position in LeMaitre Vascular in Q1 2018 and held it in 3 quarters.
  • Mount Yale Investment Advisors's LeMaitre Vascular position peaked at $28K in Q1 2018.
  • 139 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2018.

Based on Mount Yale Investment Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.